Inositol: Clinical Trials

95 trials of Inositol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

53 completed, 18 unknown, 9 recruiting, 6 terminated. 48 Not applicable, 16 Phase 4, 14 Phase 2, 12 Phase 3, 6 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable48Completed 26, Recruiting 7, Unknown 6, Not yet recruiting 3, Terminated 3, Active not recruiting 2, Suspended 1
Phase 416Completed 12, Unknown 2, Terminated 1, Withdrawn 1
Phase 214Completed 8, Unknown 4, Terminated 1, Withdrawn 1
Phase 312Unknown 5, Completed 4, Recruiting 2, Terminated 1
Phase 16Completed 3, Not yet recruiting 1, Terminated 1, Withdrawn 1
Early Phase 12Unknown 2

Follow Inositol: new trials by email Literature Review of Inositol trials Research Report on Inositol

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Myo-Inositol Alone Versus Myo-Inositol Plus Alpha-Lactalbumin in Women With Polycystic Ovary Syndrome
Myo-inositol, Alpha-Lactalbumin - Polycystic Ovary Syndrome (PCOS)
Not applicableNot yet recruitingQuaid-e-Azam Medical College822026-09-012026-06-09
Inositol and Metformin Administration in Mediterranean Diet and Low-Carbohydrate Diets in Women With PCOS
Metformin, İnositol, Folic Acid - PCOS (Polycystic Ovary Syndrome), Insulin Resistance
Not applicableRecruitingDicle University902026-08-132026-10-16
Enhancing PCOS Management for Better Outcomes of Intracytoplasmic Sperm Injection
Metformin monotherapy, Myoinositol and metformin, pioglitazone and metformin - Polycystic Ovarian Syndrome (PCOS)
Not applicableActive not recruitingBeni-Suef University1502026-05-172026-05-22
Metformin Versus Myo-inositol in the Management of Polycystic Ovarian Disease: A Comparative Study
Myoinositol, Metformin - Polycystic Ovarian Syndrome (PCOS)
Phase 1Not yet recruitingFatima Tariq602026-05-012026-03-10
The Impact of Myo-Inositol on Glycemic Control and Oxidative Stress in Gestational Diabetes Mellitus
Myo-inositol 2 g + Folic acid 200 µg, Folic acid 200 µg, Insulin therapy - Gestational Diabetes Mellitus (GDM)
Not applicableRecruitingMedical University of Vienna402026-03-232026-07-06
Efficacy of Alpha Lipoic Acid Combined With Myo-Inositol in Non-Diabetic PCOS Patients
Myo-inositol, Folic Acid, Alpha Lipoic Acid - Poly Cystic Ovary Syndrome
Phase 3RecruitingBeni-Suef University1802026-03-102026-06-05
Antenatal Myo-inositol Supplementation in Pre-existing Diabetes
Myo-inositol and folic acid supplement, Folic acid supplement - Perinatal and Neonatal Outcomes in Pregnancies With Type 2 Diabetes Mellitus (T2DM)
Not applicableRecruitingNational University Hospital, Singapore1822025-12-012025-12-09
Effect of Levocarnitine Plus Myoinositol Versus Myoinositol Alone on Hormonal and Insulin Resistance in PCOS Women
Myoinositol, Levo-Carnitine - Polycystic Ovary Syndrome (PCOS)
Not applicableRecruitingMst.Sumyara Khatun722025-09-192025-12-19
Local Treatment of Breast Pain Based on the Daily Use of a Topical Gel
inositol - Mastalgia
Not applicableRecruitingLo.Li.Pharma s.r.l502025-09-112026-02-13
Letrozole Versus Letrozole and Inositol
Letrozole tablets - Polycystic Ovary Syndrome
Not applicableCompletedAl-Azhar University1002025-08-012026-10-14
Myo-Inositol and D-Chiro-Inositol for Menstrual Irregularities and Hormone Changes in Women With Polycystic Ovarian Syndrome
Myo-Inositol and D-Chiro-Inositol Combination Therapy, placebo (folic acid) - Polycystic Ovary Syndrome (PCOS), Myo-inositol
Phase 4CompletedNishtar Medical University602025-06-012026-07-14
Treatment of Menstrual Cycle Alterations in Adolescents
myo-Inositol plus DIoscorea Villosa - Amenorrhea, Oligomenorrhea
Not applicableCompletedLo.Li.Pharma s.r.l412025-06-012026-10-09
Metformin vs Inositol vs Diet vs Combination Therapy in PCOS
Metformin Hydrochloride, Myo-Inositol, Dietary Restriction - Polycystic Ovary Syndrome, Insulin Resistance
Not applicableCompletedIslamabad Medical and Dental College1922025-05-212026-02-02
Myo-inositol During Pregnancy to Prevent Gestational Diabetes
Myo-inositol, Myo-inositol placebo - Pregnancy Related
Not applicableRecruitingTufts Medical Center402025-03-012025-04-29
Glucophage Plus Myo-Inositol vs Glucophage in Glycemic Control Among Patients With Gestational Diabetes Mellitus
Myo-Inositol, Glucophage - Gestational Diabetes Mellitus (GDM)
Not applicableNot yet recruitingUniversity of Health Sciences Lahore902025-03-012025-02-25
Impact of Myo-Inositol Alone vs Myo-Inositol Plus Metformin on Conception, Adherence, and Tolerability in PCOS
Myoinositol, Metformin 1500 mg daily - PCOS (Polycystic Ovary Syndrome)
Phase 3CompletedPAEC general hospital1202025-01-012026-01-07
Myo-inositol Versus Metformin in Patients With Polycystic Ovarian Syndrome to Treat Obesity
Myo-inositol, Metformin - Polycystic Ovarian Syndrome
Not applicableCompletedMuhammad Aamir Latif602024-11-292026-02-04
Myoinositol vs. Metformin for Polycystic Ovarian Syndrome (PCOS): Impact on Metabolic Health and Fertility
Metformin Hydrochloride 500 MG, Myoinositol - PCOS
Not applicableCompletedBenha University1562024-11-252025-07-10
Treatment of Women With Hyperandrogenic PCOS With Two Different Ratios of Myo-inositol:D-chiro-inositol: A Comparison
Myo-Inositol and D-Chiro-Inositol (40:1), Myo-Inositol and D-Chiro-Inositol (3.6:1) - Polycystic Ovarian Syndrome (PCOS)
Not applicableCompletedLo.Li.Pharma s.r.l302024-11-012025-04-08
Myo-inositol and Selenium in Indeterminate Thyroid Nodules (TIR3a)
Myo-Inositol 600 mg + Selenium 83 mcg - Thyroid Nodule
Not applicableRecruitingRegina Elena Cancer Institute302024-10-232026-08-26

Showing 20 of 95. Sign in to see all of them.

Conditions studied

Polycystic Ovary Syndrome (39)  ·  Insulin Resistance (14)  ·  Diabetes, Gestational (12)  ·  Infertility (10)  ·  Metabolic Syndrome (6)  ·  Diabetes Mellitus (4)  ·  Hyperandrogenism (4)  ·  Infertility, Female (4)  ·  Anovulation (3)  ·  Obesity (3)  ·  Premature Birth (3)  ·  Amenorrhea (2)  ·  Bipolar Disorder (2)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Depression (2)

Sponsors

Lo.Li.Pharma s.r.l (11)  ·  AGUNCO Obstetrics and Gynecology Centre (10)  ·  Beni-Suef University (5)  ·  University of Messina (5)  ·  Catholic University of the Sacred Heart (3)  ·  Massachusetts General Hospital (3)  ·  Mst.Sumyara Khatun (3)  ·  American University of Beirut Medical Center (2)  ·  G. d'Annunzio University (2)  ·  Kafrelsheikh University (2)  ·  Khyber Medical University Peshawar (2)  ·  National Cancer Institute (NCI) (2)  ·  Università degli Studi dell'Insubria (2)  ·  Al-Azhar University (1)  ·  Assistance Publique - Hôpitaux de Paris (1)

Countries

Italy (32)  ·  United States (14)  ·  Egypt (9)  ·  Pakistan (9)  ·  Bangladesh (3)  ·  Belgium (3)  ·  Canada (2)  ·  France (2)  ·  Lebanon (2)  ·  Austria (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Cyprus (1)  ·  Georgia (1)  ·  Mexico (1)

Top investigators

Janet Wozniak, MD (3)  ·  Claudio Celentano, MD (2)  ·  Fabio Ghezzi, M.D. (2)  ·  Massimo Franchi, M.D. (2)  ·  Rosario D'Anna, professor (2)  ·  Scott Roseff, MD (2)  ·  Simone Garzon, M.D. (2)  ·  Vittorio Unfer, MD (2)  ·  Abbot R Laptook, MD (1)  ·  Abhik Das, PhD (1)  ·  Amy M Valent, DO (1)  ·  Andrew Copp, Prof (1)  ·  Anthony P Cheung, MBBS MPH MBA (1)  ·  Antoine Abu Mussa, MD (1)

Results publications

PMID 36790138, PMID 11765093, PMID 15005752, PMID 15110730, PMID 15330403, PMID 15349007, PMID 15465989, PMID 15541061, PMID 15569893, PMID 15677618, PMID 15723025, PMID 15898966, PMID 15950022, PMID 15960566, PMID 16023735, PMID 16168792, PMID 16176440, PMID 16197928, PMID 16338761, PMID 16339615, PMID 16339616, PMID 16426088, PMID 16448626, PMID 16449473, PMID 16449474, PMID 16552982, PMID 16566627, PMID 16595351, PMID 16635643, PMID 16675760, PMID 16677228, PMID 16816280, PMID 16816301, PMID 16928441, PMID 17007487, PMID 17042830, PMID 17392295, PMID 17404119, PMID 17728418, PMID 18227782, PMID 18399724, PMID 18681768, PMID 19210946, PMID 20409444, PMID 21324454, PMID 22098628, PMID 23561230, PMID 24601829, PMID 25881582, PMID 26228414

NIH funding

2018 (1), N01CN35157 (1), P30CA015083 (1), P30CA060553 (1), R01AT009484 (1), U10HD021364 (1), U10HD021373 (1), U10HD021385 (1), U10HD027851 (1), U10HD027853 (1), U10HD027856 (1), U10HD027880 (1), U10HD027904 (1), U10HD034216 (1), U10HD036790 (1)